Join us this March for the first ever CURE Patient-Focused Sessions, taking place at the Miami Breast Cancer Conference! 

To start your customized experience click the start button
Customize ?  
Cancer Types
Quick Links
Award Programs
About Us
Contact Us
Privacy Policy
Terms & Conditions
Face Book
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.


Jessica Skarzynski
After seeing encouraging phase 1 results, the phase 2 portion of a clinical trial currently evaluating the efficacy of the BET inhibitor CPI-0610 in patients with myelofibrosis has been enhanced and expanded.
Brielle Urciuoli
For many patients with polycythemia vera, hydroxyurea is a beneficial first-line treatment. But that’s not the case for everyone. One expert discusses which drugs should be used next.
Katie Kosko
Understanding the type of MPN can affect how care is carried out and how well it may work.
Brielle Urciuoli
Diagnosing and treating the disease before it turns into AML is a key area of study, said Srdan Verstovsek, M.D., Ph.D., medical oncologist and professor in the Department of Leukemia at The University of Texas MD Anderson Cancer Center.
Katie Kosko
Researchers discovered that at least 50 percent of people surveyed had an employment change because of their disease.
Laura Michaelis, M.D.
Genomics are starting to play a crucial role in treatment planning for patients with essential thrombocythemia.
Patients with essential thrombocythemia should know the signs and symptoms of blood clots.
Kathleen Weis, CEO
Since these are difficult diseases to treat, research has been quite slow over the last decade or so, but continues to pick up, developing new treatments for patients with these diseases.
Katie Kosko
“What we really want this to do is be a place for patients to facilitate conversations with their doctor,” Michelle Woehrle, executive director of MPN Research Foundation (MPNRF) said.
Kristie L. Kahl
Recent research showed first-degree relatives of patients with certain types of blood cancers may be at an increased risk for such disease, highlighting the importance of counseling, gene testing and surveillance.

Sign In

Not a member? Sign up now!
Continue without login

Sign Up

Patient Caregiver Advocate Other